1 year return (CAGR)
-50.72%
Immuneering Corp Exchange (NASDAQ, USD)
IMRX
4.38
-0.04 (-0.89%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-16.62%
5 year return (CAGR)
-28.27%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
287.26M
Price/Sales
795.82
Ent value
257.25M
Price/Book
1.51
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.51%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.55 |
| Daily high | 4.57 |
| Daily low | 4.38 |
| Daily Volume | 539K |
| All-time high | 32.84 |
| 1y analyst estimate | 17.17 |
| Beta | 0.39 |
| EPS (TTM) | -0.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| IMRX | S&P500 | |
| Current price drop from All-time high | -86.66% | -1.29% |
| Highest price drop | -96.86% | -56.47% |
| Date of highest drop | 16 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -77.95% | -10.68% |
| Avg time to new high | 129 days | 12 days |
| Max time to new high | 1251 days | 1805 days |
News
